Investors • Strategic partners • Institutions

Climate infrastructure built for evidence-led scale.

Greenovo sits at the intersection of landfill methane mitigation, municipal waste infrastructure, waste-to-energy, bio-engineering and the circular economy — with a growing validation base and a clear route toward institutional diligence.

Investment thesis

Why Greenovo is building in a consequential market

Landfill methane, legacy waste and urban waste processing are large public-infrastructure challenges requiring solutions that can work under real Indian field conditions.

01

Problem urgency

Landfill methane contributes to greenhouse-gas risk, fire hazards, air-quality issues and operational constraints around legacy-waste processing.

02

Field-tested pathway

Greenovo has completed an authorised pilot using biological delivery systems in an active landfill environment, providing a practical base for further validation.

03

Institutional traction

The company now has an Assam Pollution Control Board recommendation and an IISER Kolkata review of the submitted pilot results.

04

Multiple revenue pathways

ULB deployment, project execution, technology partnerships, waste-to-energy applications and future ESG/carbon pathways can support diversified scale.

Current readiness

Evidence before valuation.

The strongest investor proposition is a transparent one: distinguish what has been demonstrated, what has been institutionally reviewed and what remains to be independently certified.

See evidence centre →
Field pilot
Documented
Institutional recommendation
Received
Scientific data review
Received
Substrate / lab package
Next-stage
Formal TRL assessment
To establish
Commercial repeatability
Scale phase

Data room roadmap

What serious investors should be able to diligence

A clean, auditable data room reduces technical and transaction friction, especially for institutional and foreign capital.

01

Technology & IP

Process description, background IP, patent status, ownership, licence rights, NDAs and freedom-to-operate review.

02

Substrate characterisation

Waste composition, moisture, organic fraction, C/N ratio, pH, leachate chemistry, heavy metals and microbial baseline.

03

Performance evidence

Calibrated gas measurements, sampling plan, control plots, chain of custody, statistical analysis and repeatability.

04

TRL & engineering

Prototype configuration, operating envelope, failure modes, dosing SOPs, field evidence and formal maturity assessment.

05

Regulatory & EHS

Site/ULB approvals, Pollution Control Board position, waste-management compliance, biosafety assessment and EHS plan.

06

Commercial & ESG

CAPEX/OPEX, pricing, unit economics, deployment model, customer pipeline, audited financials and defensible ESG metrics.

TRL pathway

Target maturity sequence

The website does not self-declare a certified TRL. The sequence below is a proposed diligence roadmap.

Pilot evidenceAuthorised field trialDocumented deployment in relevant landfill conditions.
TargetTRL 5–6Validated prototype in a relevant environment with stronger independent evidence.
TargetTRL 7System prototype demonstrated in an operational environment.
CommercialTRL 8–9Qualified system and repeatable deployment at commercial scale.

Foreign capital preparedness

Build the company as carefully as the technology.

Foreign investment should be structured only after transaction-specific legal, FEMA/FDI, tax and sectoral review.

Corporate hygiene

Clean cap table, statutory registers, MCA filings, audited financials, board approvals, beneficial-ownership records and material contracts.

IP clarity

Background IP, joint-development rights, patent ownership, licensing, confidentiality and commercialisation rights should be unambiguous.

Claims discipline

Separate measured historical results from forward-looking projections, carbon-credit assumptions, TRL targets and commercial forecasts.

Strategic conversations

For investors who want to diligence the technology, not just the story.

Greenovo welcomes discussions with climate-tech and impact funds, venture capital, strategic industrial partners, development institutions and government-backed programmes.

Request a discussionReview validation evidence